Calcipotriol monohydrate
CAS No. 147657-22-5
Calcipotriol monohydrate ( —— )
产品货号. M29615 CAS No. 147657-22-5
Calcipotriol monohydrate is an analog of Vitamin D3 with a high affinity for the vitamin D receptor. Calcipotriol monohydrate can be used for studies about psoriasis.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥381 | 有现货 |
|
10MG | ¥543 | 有现货 |
|
25MG | ¥1045 | 有现货 |
|
50MG | ¥1920 | 有现货 |
|
100MG | ¥3540 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Calcipotriol monohydrate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Calcipotriol monohydrate is an analog of Vitamin D3 with a high affinity for the vitamin D receptor. Calcipotriol monohydrate can be used for studies about psoriasis.
-
产品描述Calcipotriol monohydrate is an analog of Vitamin D3 with a high affinity for the vitamin D receptor. Calcipotriol monohydrate can be used for studies about psoriasis.(In Vitro):Calcipotriol monohydrate (100, 10, and 1 ng/mL) significantly upregulated the expression of NKp30 on the surface of NK cells after 4 h incubation. When NHEK cells are not stimulated with IL-17A or IL-22, Calcipotriol monohydrate slightly enhances (0.2 nM) IL-8 mRNA expression or has no effect (2-20 nM). The addition of IL-17A and IL-22 markedly increased the mRNA expression of IL-8, confirming our previous study. This enhanced IL-8 mRNA expression is suppressed by Calcipotriol monohydrate (2, 20 and 40 nM) in a dose dependent manner.(In Vivo):The weight gain is significantly smaller in the groups treated with Diclofenac plus Calcipotriol monohydrate (p=0.018) and Diclofenac plus DFMO plus Calcipotriol monohydrate (p=0.002) compare with placebo (linear regression model).
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number147657-22-5
-
分子量430.6
-
分子式C27H42O4
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO.[H][C@@]12CC[C@H]([C@H](C)\C=C\[C@@H](O)C3CC3)[C@@]1(C)CCC\C2=C/C=C1/CC(O)CC(O)C1=C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
Setipiprant
Setipiprant is an orally available, selective CRTH2 antagonist (IC50: 6.0 nM). CRTH2 is a G protein-coupled receptor for prostaglandin (PGD2).
-
Etoxybamide
Etoxybamide is a drug candidate for sedative (hypnotic).
-
Tertiapin LQ
Blocker of Kir1.1 channels; displays >250-fold selectivity for Kir1.1 (Kd values are 1.1, 274 and 361 nM for Kir1.1, Kir3.1/3.2 and Kir3.1/3.4 respectively). Derivative of tertiapin-Q.